Who Owns MDCX?

Medicus Pharma Ltd. Common Stock — Institutional Ownership & 13F Holdings

$0.29

-0.00 (-0.71%)

Market Cap

$6.5M

Shares Outstanding

22,040,944

Institutional Holders

6

Total Inst. Value

$11.3M

% of Float Held

62.2%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Interchange Capital Partners, LLC$6.2M1,661,871
2ARMISTICE CAPITAL, LLC$4.7M1,266,000
3Private Advisor Group, LLC$211K56,750
4PATRIOT INVESTMENT MANAGEMENT GROUP, INC.$109K29,203
5UBS Group AG$79K21,262
6OSAIC HOLDINGS, INC.$19K5,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold MDCX?

As of Q1 2025, 6 institutional investors report holding MDCX (Medicus Pharma Ltd. Common Stock) in their 13F filings.

What percentage of Medicus Pharma Ltd. Common Stock is owned by institutions?

Institutional investors hold approximately 62.2% of Medicus Pharma Ltd. Common Stock's float as reported in SEC 13F filings.

Which hedge fund owns the most MDCX?

The largest institutional holder of MDCX is Interchange Capital Partners, LLC with $6.2M in shares.

Are institutions buying or selling MDCX?

This quarter, 4 institutions opened new positions in MDCX and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.